Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $992.70 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $226.36 | 11 | $0 (2024) |
| ABBVIE INC. | $144.90 | 8 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $80.50 | 3 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $79.29 | 5 | $0 (2022) |
| Teleflex LLC | $78.46 | 3 | $0 (2022) |
| EISAI INC. | $68.43 | 3 | $0 (2022) |
| Baxter Healthcare | $61.12 | 2 | $0 (2024) |
| Davol Inc. | $52.93 | 1 | $0 (2022) |
| Smith+Nephew, Inc. | $52.07 | 3 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $48.09 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $197.74 | 9 | Merck Sharp & Dohme LLC ($78.33) |
| 2023 | $138.48 | 5 | Alexion Pharmaceuticals, Inc. ($56.32) |
| 2022 | $356.48 | 15 | ABBVIE INC. ($82.79) |
| 2021 | $182.56 | 9 | Merck Sharp & Dohme Corporation ($66.73) |
| 2020 | $74.16 | 4 | Merck Sharp & Dohme Corporation ($49.28) |
| 2019 | $43.28 | 3 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($28.57) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $21.76 | General |
| 08/20/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/07/2024 | Alcresta Therapeutics, Inc. | RELIZORB (Device) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/06/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: CRITICAL CARE | ||||||
| 04/16/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/28/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/20/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/13/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Surgical Care | ||||||
| 01/31/2024 | Smith+Nephew, Inc. | Pico 14 (Device), RENASYS TOUCH | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 12/05/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: Rare Disease | ||||||
| 10/17/2023 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $41.86 | General |
| Category: Surgical Care | ||||||
| 09/26/2023 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Pharma Products | ||||||
| 09/20/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Rare Disease | ||||||
| 05/22/2023 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Recon-Skin and Wound | ||||||
| 12/21/2022 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $52.93 | General |
| Category: BD Interventional Surgery | ||||||
| 12/19/2022 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/06/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/22/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Pharma Products | ||||||
| 09/14/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Rare Disease | ||||||
| 08/09/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/25/2022 | Teleflex LLC | QuikClot (Device) | Food and Beverage | In-kind items and services | $30.93 | General |
| Category: Emergency Medicine | ||||||
| 06/07/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/24/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Gastroenterology | ||||||
| 05/10/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/24/2022 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 70 | 213 | $144,659 | $36,525 |
| 2022 | 4 | 125 | 271 | $175,505 | $40,975 |
| 2021 | 5 | 189 | 473 | $287,116 | $76,796 |
| 2020 | 6 | 219 | 477 | $289,809 | $76,201 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 70 | 213 | $144,659 | $36,525 | 25.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 76 | 217 | $146,920 | $38,107 | 25.9% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 11 | 16 | $7,151 | $1,103 | 15.4% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 22 | 22 | $13,108 | $994.52 | 7.6% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 16 | 16 | $8,327 | $770.37 | 9.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 124 | 391 | $256,931 | $70,707 | 27.5% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 22 | 34 | $11,152 | $3,086 | 27.7% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 15 | 17 | $10,438 | $1,191 | 11.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 14 | $4,209 | $1,186 | 28.2% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2021 | 16 | 17 | $4,386 | $625.94 | 14.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 136 | 371 | $243,900 | $67,843 | 27.8% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 18 | 36 | $11,808 | $3,329 | 28.2% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 12 | 14 | $7,879 | $1,692 | 21.5% |
| 31622 | Diagnostic examination of lung airways using an endoscope | Facility | 2020 | 11 | 11 | $8,129 | $1,219 | 15.0% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2020 | 30 | 32 | $8,978 | $1,192 | 13.3% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 12 | 13 | $9,115 | $925.78 | 10.2% |
About Dr. Hina Faisal, M.D
Dr. Hina Faisal, M.D is a Critical Care Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2011. The National Provider Identifier (NPI) number assigned to this provider is 1821385709.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hina Faisal, M.D has received a total of $992.70 in payments from pharmaceutical and medical device companies, with $197.74 received in 2024. These payments were reported across 45 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($992.70).
As a Medicare-enrolled provider, Faisal has provided services to 603 Medicare beneficiaries, totaling 1,434 services with total Medicare billing of $230,497. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Anesthesiology
- Location Houston, TX
- Active Since 06/29/2011
- Last Updated 07/14/2020
- Taxonomy Code 207LC0200X
- Entity Type Individual
- NPI Number 1821385709
Products in Payments
- DIFICID (Drug) $113.20
- ULTOMIRIS (Biological) $80.50
- TEFLARO (Drug) $73.63
- AVYCAZ (Drug) $71.27
- Lenvima (Drug) $68.43
- ZERBAXA (Drug) $67.48
- QuikClot (Device) $66.56
- XIFAXAN (Drug) $66.31
- PERCLOT (Device) $61.12
- Phasix Mesh (Device) $52.93
- LIVTENCITY (Drug) $29.92
- RELIZORB (Device) $29.74
- TERLIVAZ (Drug) $29.46
- COLLAGENASE SANTYL (Drug) $28.69
- Integra (Device) $26.18
- RECARBRIO (Drug) $23.92
- Pico 14 (Device) $23.38
- ALDEN SOFT IRREGULAR (Device) $14.71
- TRULANCE (Drug) $12.98
- AIRWAY MANAGEMENT - LMA, RUSCH & TELEFLEX BRANDS (Device) $11.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Houston
Edwin Parsley, D.o, D.O
Critical Care Medicine — Payments: $251,404
Faisal Masud, M.d, M.D
Critical Care Medicine — Payments: $195,867
Dr. Bindu Akkanti, M.d, M.D
Critical Care Medicine — Payments: $133,512
Sergio Trevino Castillo, M.d, M.D
Critical Care Medicine — Payments: $132,750
Dr. Ivan Rosas, M.d, M.D
Critical Care Medicine — Payments: $121,377
Dr. Dileep Puppala, M.d, M.D
Critical Care Medicine — Payments: $105,456